CRSP · Forms 3, 4, 5
Insider trades at CRISPR Therapeutics AG
3 insiders sold $1.7M of CRISPR Therapeutics AG stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for CRISPR Therapeutics AG (CRSP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Simeon George | Director | Option exercise | 30,000 | $14.00 | $420K | Form 4 | |
| Simeon George | Director | Sell (10b5-1 plan) | 14,514 | $49.63 | $720K | Form 4 | |
| James R. Kasinger | General Counsel and Secretary | Sell | 1,040 | $49.26 | $51K | Form 4 | |
| Samarth Kulkarni | Chief Executive Officer | Sell | 4,098 | $49.26 | $202K | Form 4 | |
| James R. Kasinger | General Counsel and Secretary | Option exercise | 2,113 | Form 4 | |||
| Samarth Kulkarni | Chief Executive Officer | Option exercise | 8,333 | Form 4 | |||
| James R. Kasinger | General Counsel and Secretary | Option exercise | 1,990 | $13.62 | $27K | Form 4 | |
| James R. Kasinger | General Counsel and Secretary | Sell (10b5-1 plan) | 1,990 | $60.04 | $119K | Form 4 | |
| James R. Kasinger | General Counsel and Secretary | Option exercise | 10,400 | $13.62 | $142K | Form 4 | |
| James R. Kasinger | General Counsel and Secretary | Sell (10b5-1 plan) | 10,400 | $60.24 | $626K | Form 4 | |
| Ali Behbahani | Director | Option exercise | 30,000 | $14.00 | $420K | Form 4 | |
| Ali Behbahani | Director | Sell | 13,679 | $57.09 | $781K | Form 4 | |
| Raju Prasad | Chief Financial Officer | Gift | 750 | Form 4 | |||
| Ali Behbahani | Director | Other | 60 | Form 4 | |||
| Ali Behbahani | Director | Other | 15 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.